Gastrointestinal chronic graft-versus-host disease: Management options

Journal of Oncology Pharmacy Practice

Volumn 13, Issue 1, 2007, Pages 49-51

  Awan, Farrukh ^a   Hamadani, Mehdi ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Aminocaproic acid; Anti fibrinolytics; Gastrointestinal bleeding; Graft versus host disease

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; BUSULFAN; CYCLOSPORIN; FLUDARABINE; PREDNISONE; PROTON PUMP INHIBITOR; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; MALE; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PATIENT CARE; PRIORITY JOURNAL;

AGED; AMINOCAPROIC ACIDS; ANTI-ULCER AGENTS; ANTIFIBRINOLYTIC AGENTS; CHRONIC DISEASE; COMBINED MODALITY THERAPY; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROTON PUMPS;

EID: 34250202254     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078155207077264     Document Type: Article

References (11)

1. Baird K, Pavletic SZ. Chronic graft versus host disease. Curr Opin Hematol 2006; 13: 426-35.
2. Pavletic SZ, Lee SJ, Socie G, Vogelsang G. Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials. Bone Marrow Transplant 2006; 38: 645-51.
3. Farag SS. Chronic graft-versus-host disease: where do we go from here? Bone Marrow Transplant 2004; 33: 569-77.
4. Grover N, Johnson A. Aminocaproic acid used to control upper gastrointestinal bleeding in radiation gastritis. Dig Dis Sci 1997; 42: 982-84.
5. Mannucci PM. Hemostatic drugs. N Engl J Med 1998; 339: 245-53.
6. Henry DA, Moxey AJ, Carless PA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2001; 00CD001886.
7. Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs 1985; 29: 236-61.
8. Cox HT, Poller L, Thomson JM. Evidence for the release of gastric fibrinolytic activity into peripheral blood. Gut 1969; 10: 404-07.
9. Henry DA, O'Connell DL. Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage. Bmj 1989; 298: 1142-46.
10. Marmaduke DP, Greenson JK, Cunningham I, Herderick EE, Cornhill JF. Gastric vascular ectasia in patients undergoing bone marrow transplantation. Am J Clin Pathol 1994; 102: 194-48.
11. Akpek G, Chinratanalab W, Lee LA, et al. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study. Biol Blood Marrow Transplant 2003; 9: 46-51.